This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Review

. 1995:10 Suppl 2:62-8.

doi: 10.1093/ndt/10.supp2.62.

R-HuEPO hyporesponsiveness--who and why?

Affiliations

PMID: 7644108
DOI: 10.1093/ndt/10.supp2.62

Review

R-HuEPO hyporesponsiveness--who and why?

T B Drüeke. Nephrol Dial Transplant. 1995.

. 1995:10 Suppl 2:62-8.

doi: 10.1093/ndt/10.supp2.62.

Author

Affiliation

¹ INSERM Unité 90, Hôpital Necker, Paris, France.

PMID: 7644108
DOI: 10.1093/ndt/10.supp2.62

No abstract available

PubMed Disclaimer

Similar articles

R-HuEPO hyporesponsiveness--who and why?
Danielson B. Danielson B. Nephrol Dial Transplant. 1995;10 Suppl 2:69-73. doi: 10.1093/ndt/10.supp2.69. Nephrol Dial Transplant. 1995. PMID: 7644109
Resistance to recombinant human erythropoietin in hemodialysis patients.
Drüeke TB. Drüeke TB. Am J Nephrol. 1990;10 Suppl 2:34-9. doi: 10.1159/000168215. Am J Nephrol. 1990. PMID: 2260616
Starting r-HuEPO in chronic renal failure: when, why, and how?
Jacobs C. Jacobs C. Nephrol Dial Transplant. 1995;10 Suppl 2:43-7. doi: 10.1093/ndt/10.supp2.43. Nephrol Dial Transplant. 1995. PMID: 7644105
[Hyporesponsiveness to recombinant human erythropoietin therapy in anemic patients on hemodialysis].
Maeda H, Hirakata H. Maeda H, et al. Nihon Rinsho. 2004 Jun;62 Suppl 6:307-11. Nihon Rinsho. 2004. PMID: 15250314 Review. Japanese. No abstract available.
The future of r-HuEPO.
Eschbach JW. Eschbach JW. Nephrol Dial Transplant. 1995;10 Suppl 2:96-109. doi: 10.1093/ndt/10.supp2.96. Nephrol Dial Transplant. 1995. PMID: 7644114 Review.

See all similar articles

Cited by

Impact of diabetes on haemoglobin levels in renal disease.
Ravanan R, Spiro JR, Mathieson PW, Smith RM. Ravanan R, et al. Diabetologia. 2007 Jan;50(1):26-31. doi: 10.1007/s00125-006-0514-y. Epub 2006 Nov 28. Diabetologia. 2007. PMID: 17131141
Factors related to erythropoietin hypo-responsiveness in patients on chronic peritoneal dialysis.
Wei M, Bargman JM, Oreopoulos DG. Wei M, et al. Int Urol Nephrol. 2007;39(3):935-40. doi: 10.1007/s11255-007-9226-6. Epub 2007 May 30. Int Urol Nephrol. 2007. PMID: 17534732
Epoetin alfa. A review of its clinical efficacy in the management of anaemia associated with renal failure and chronic disease and its use in surgical patients.
Dunn CJ, Wagstaff AJ. Dunn CJ, et al. Drugs Aging. 1995 Aug;7(2):131-56. doi: 10.2165/00002512-199507020-00007. Drugs Aging. 1995. PMID: 7579784 Review.
Elderly patients on chronic hemodialysis: effect of the secondary hyperparathyroidism on the hemoglobin level.
Neves PL, Triviño J, Casaubon F, Romão P, Mendes P, Bexiga I, Pinto I, Santos V, Bernardo I. Neves PL, et al. Int Urol Nephrol. 2002;34(1):147-9. doi: 10.1023/a:1021380609993. Int Urol Nephrol. 2002. PMID: 12549658
IGF-1 is an independent risk factor for anemia in diabetic pre-dialysis patients.
Kim DH, Kim TY, Kim SM, Yoo SJ, Oh DJ, Yu SH. Kim DH, et al. Korean J Intern Med. 2007 Sep;22(3):186-91. doi: 10.3904/kjim.2007.22.3.186. Korean J Intern Med. 2007. PMID: 17939336 Free PMC article.

See all "Cited by" articles

Publication types

Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
- Silverchair Information Systems
Other Literature Sources
- The Lens - Patent Citations Database
Medical
- MedlinePlus Health Information